BIOADAPTIVES, INC.
PublicBiotech · Las Vegas, NV
Financials
FY2013–FY2025 (no data for FY2016, FY2017) · from SEC filings · hover any figure for its sourceChart shows the most recent 8 fiscal years; 3 earlier years are in the table below.
Figures as reported by the issuer in the filing shown on hover. Each year’s pill shows the assurance level of its filed statements — audited, reviewed (CPA review, less than an audit), or unaudited, as the filing’s own report or certification states it. A dashed pill marked * is inferred instead: the SEC minimum for an offering that size, which the issuer may have exceeded. No pill means we couldn’t tell. Headcount is the filing’s point-in-time count, not a year-end average. Manually corrected figures are marked “Corrected”.
Valuation over rounds
Pre-money — the valuation set before each round’s money came inDotted grey bars are our estimate for rounds that didn't state one: the round's share price × the shares outstanding in its filings. Same measure as blue, but rougher.
Cap table
Share counts as of Jun 30, 2026| Class | Outstanding | Votes / share | Share of total | Last price |
|---|---|---|---|---|
| Series C Preferred Stockpreferred(as of Jun 30, 2025) | 1,000,000 | — | 2.66% | — |
| Series B Preferred Stockpreferred(as of Jun 30, 2025) | 9,667 | — | 0.03% | — |
| Common stock | 36,595,174 | 1 | 97.3% | $0.0075Mar 2022 |
| Total | 37,604,841 | 100% |
Shares outstanding over timein today's share terms
Changes in named holdersshares in today's terms · % of all shares at the time
- Edward E. Jacobs, Jr2.2M May 2020 → 2.2M (4.02%) Mar 2021
Principal holders% as the filing states it, Apr 14, 2026
- Director Series D Mark P. Frissora10,000,000 common stock100.0%of company
Sold to the crowd
- Reg A+ · Mar 202226,666,667 Common Stock at $0.0075$200K
From the company's SEC filings: share counts per class, each class's voting and conversion terms, and the holders of 20% or more that Form C requires (officers and 10%+ holders on Form 1-A). Filings name only large holders, so most owners — including crowd investors — are not listed, and a holder's percentage may be of its own class rather than of the whole company. Prices and crowd share counts are in today's share terms — adjusted for splits and conversions since they were sold. Hover a figure for its filing.
Fundraising history
Team
3 peopleNames and titles as disclosed on SEC Form 1-A. Bios and photos come from the platform campaign page and may be out of date.
SEC filings
View all 58 filings on EDGAR- Form 10-QAug 19, 20260001640334-26-001393EDGAR
- Form 10-QMay 15, 20260001640334-26-000911EDGAR
- Form 10-KApr 14, 20260001640334-26-000718EDGAR
- Form 10-QNov 14, 20250001640334-25-002081EDGAR
- Form 10-QAug 14, 20250001640334-25-001493EDGAR
- Form 10-QMay 13, 20250001640334-25-000834EDGAR
- Form 10-KApr 15, 20250001640334-25-000660EDGAR
- Form 10-QNov 19, 20240001640334-24-001752EDGAR
About this data. Figures are compiled from public sources — SEC EDGAR filings (Form C, C-AR, 1-A, 1-K) and funding-platform pages — and may be delayed, incomplete, or restated by the issuer. Financial statements are as reported by the issuer; each year is labeled with its assurance level (audited / reviewed / unaudited). A valuation cap is the conversion ceiling of a SAFE or convertible note, not an agreed company valuation; post-money figures are computed as pre-money plus amount raised and are not a traded price. Crowdonomics is not a broker-dealer, funding portal, or investment adviser; nothing here is investment advice or an offer to sell securities. Verify all figures against the linked EDGAR filings.